These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15823283)

  • 1. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
    Lim HS; Lip GY; Blann AD
    Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
    Lim HS; Blann AD; Chong AY; Freestone B; Lip GY
    Diabetes Care; 2004 Dec; 27(12):2918-24. PubMed ID: 15562207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
    Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
    Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
    Jaumdally RJ; Goon PK; Varma C; Blann AD; Lip GY
    J Intern Med; 2010 Apr; 267(4):385-93. PubMed ID: 19754853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
    J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
    Lee KW; Lip GY; Blann AD
    Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
    Freestone B; Chong AY; Lim HS; Blann A; Lip GY
    Ann Med; 2005; 37(5):365-72. PubMed ID: 16179272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
    Lim HS; Tayebjee MH; Tan KT; Patel JV; Macfadyen RJ; Lip GY
    Thromb Res; 2008; 122(3):307-13. PubMed ID: 18054068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained Elevation of Vascular Endothelial Growth Factor and Angiopoietin-2 Levels After Transcatheter Aortic Valve Replacement.
    Ben-Shoshan J; Steinvil A; Arbel Y; Topilsky Y; Barak L; Entin-Meer M; Levy R; Schwartz AL; Keren G; Finkelstein A; Banai S
    Can J Cardiol; 2016 Dec; 32(12):1454-1461. PubMed ID: 27720271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
    Caine GJ; Blann AD; Stonelake PS; Ryan P; Lip GY
    Eur J Clin Invest; 2003 Oct; 33(10):883-90. PubMed ID: 14511360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.
    Nadar SK; Blann AD; Lip GY
    J Intern Med; 2004 Oct; 256(4):331-7. PubMed ID: 15367176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma angiopoietin-2 outperforms other markers of endothelial injury in prognosticating pediatric ARDS mortality.
    Zinter MS; Spicer A; Orwoll BO; Alkhouli M; Dvorak CC; Calfee CS; Matthay MA; Sapru A
    Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(3):L224-31. PubMed ID: 26660787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction.
    Malecki MT; Osmenda G; Walus-Miarka M; Skupien J; Cyganek K; Mirkiewicz-Sieradzka B; damek-Guzik TA; Guzik TJ; Sieradzki J
    Eur J Clin Invest; 2008 Dec; 38(12):925-30. PubMed ID: 19021717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
    Caine GJ; Ryan P; Lip GY; Blann AD
    Cancer Lett; 2007 Jun; 251(2):296-301. PubMed ID: 17240049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
    Nadar S; Blann AD; Lip GY
    Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of circulating angiogenic factors in diabetic kidney disease].
    Martynov SA; Shestakova MV; Kutyrina IM; Il'in AV; Arbuzova MI; Dedov II
    Vestn Ross Akad Med Nauk; 2013; (2):35-42. PubMed ID: 23819327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients.
    Pawlak K; Myśliwiec M; Pawlak D
    Adv Med Sci; 2010; 55(2):196-203. PubMed ID: 20439183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.